EIP
OGN icon

Ellis Investment Partners’s Organon & Co OGN Stock Holding History

Ellis Investment Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-180
Closed -$4K – 563
2022
Q3 		$4K Sell
180
-10
-5% -$302 ﹤0.01% 683
2022
Q2 		$6K Hold
190
– – ﹤0.01% 661
2022
Q1 		$6K Sell
190
-19
-9% -$650 ﹤0.01% 676
2021
Q4 		$6K Sell
209
-10
-5% -$326 ﹤0.01% 686
2021
Q3 		$7K Buy
+219
New +$7.01K ﹤0.01% 650

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ellis Investment Partners's OGN Position: Q4 2022 in Review

Ellis Investment Partners sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 180 shares — an estimated $4K sold.

Ellis Investment Partners first reported a position in OGN in Q3 2021 and held it in 5 quarters. The position peaked at $7K in Q3 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Ellis Investment Partners reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 180 Organon & Co shares in Q4 2022, an estimated $4K.
  • Ellis Investment Partners first reported a position in Organon & Co in Q3 2021 and held it in 5 quarters.
  • Ellis Investment Partners's Organon & Co position peaked at $7K in Q3 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.